Integra LifeSciences (IART)
(Delayed Data from NSDQ)
$14.13 USD
-1.25 (-8.13%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $14.13 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
IART 14.13 -1.25(-8.13%)
Will IART be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IART based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IART
Should You Continue to Hold Integra Stock in Your Portfolio Now?
Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key Metrics
IART: What are Zacks experts saying now?
Zacks Private Portfolio Services
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates
IART Stock May Rise on First Enrollment in AERA Pediatric Registry
Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?
Other News for IART
Fell Below 20 Day Moving Average appears for IART after 8.13% move
Is IART primed for upward momentum? Crossed Above 20 Day Moving Average shows up after gaining 3.92%
Is IART ready to move lower? 20 Day Moving Average Resistance shows up after declining 0.2%
IART forms Non-ADX 1,2,3,4 Bullish on September 16
20 Day Moving Average Support appears for IART after 0.07% move